Canagliflozin Increases Postprandial Total Glucagon-Like Peptide 1 Levels in the Absence of α-Glucosidase Inhibitor Therapy in Patients with Type 2 Diabetes: A Single-Arm, Non-randomized, Open-Label Study

類似資料

• Add-On Therapy with DPP-4 Inhibitors May Improve Renal Function Decline in α-Glucosidase Inhibitor and Metformin Users: A Retrospective Observational Study
  著者:: Osonoi, Takeshi, 等
  出版事項: (2020)
• Efficacy of ipragliflozin as monotherapy or as add‐on therapy with other oral antidiabetic medications for treating type 2 diabetes in Japanese patients with inadequate glycemic control: A subgroup analysis based on patient characteristics
  著者:: Osonoi, Takeshi, 等
  出版事項: (2017)
• Effect of Hemodialysis on Plasma Glucose Profile and Plasma Level of Liraglutide in Patients with Type 2 Diabetes Mellitus and End-Stage Renal Disease: A Pilot Study
  著者:: Osonoi, Takeshi, 等
  出版事項: (2014)
• Relationships between lifestyle patterns and cardio-renal-metabolic parameters in patients with type 2 diabetes mellitus: A cross-sectional study
  著者:: Ogihara, Takeshi, 等
  出版事項: (2017)
• Poor sleep quality is associated with increased arterial stiffness in Japanese patients with type 2 diabetes mellitus
  著者:: Osonoi, Yusuke, 等
  出版事項: (2015)